ZCMD News and Press, Zhongchao Inc - Class A From 12/05/22

Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform PR Newswire SHANGHAI , Dec. 5, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company...

Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market PR Newswire SHANGHAI , Nov. 3, 2022 /PRNewswir...

Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications PR Newswire SHANGHAI , Sept. 28, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based inter...

Zhongchao Inc. Establishes Zhixun Internet Hospital to Provide Patient with Management Services Focusing on the Oncology and Other Major Diseases PR Newswire SHANGHAI , Sept. 15, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the ...

Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management PR Newswire SHANGHAI , Sept 1, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology compan...

Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course PR Newswire SHANGHAI , June 13, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology c...

Zhongchao press release (NASDAQ:ZCMD): FY GAAP EPS of $0.01. Revenue of $16.29M (-9.4% Y/Y). For further details see: Zhongchao GAAP EPS of $0.01, revenue of $16.29M

Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results PR Newswire SHANGHAI , May 9, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthc...

Gainers: BioVie (BIVI) +16%. Progenity (PROG) +16%. Kezar Life Sciences (KZR) +14%. Codiak BioSciences (CDAK) +13%. Ensysce Biosciences (ENSC) +10%. Losers: Nymox Pharmaceutical (NYMX) -29%. HTG Molecular Diagnostics (HTGM) -14%. Zhongchao (ZC...

Gainers: Volt Information Sciences (NYSE:VOLT) +96%. Red Cat Holdings (OTCQB:RCAT) +46%. Turquoise Hill Resources (NYSE:TRQ) +32%. Zhongchao (NASDAQ:ZCMD) +29%. Mullen Automotive (NASDAQ:MULN) +28%. AgriFORCE Growing Systems (NASDAQ:AGRI) +26%. FirstMark Horizon Acquisition (NYSE:FMAC) +23%. ...